SK

Sushant Kumar

Active Director Director DIN 07759607
DIN 07759607 First appointment Mar 2017 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2017
Shareholding value •••• Premium profile

About Sushant Kumar

Data last updated:

Sushant Kumar is a Director at Trystar Pharma Private Limited (since 2017). The company operates in Chemicals. Trystar Pharma Private Limited reported revenue of ₹7.1 Lakh (FY 2025).

DIN 07759607
Primary Designation Director
Industry Chemicals
First Appointment 24 Mar 2017
Oldest Company Age 9 yrs
Largest company Trystar Pharma Private Limited · ₹7.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trystar Pharma Private Limited U24100DL2017PTC315026
Director24 Mar 20172017₹7.1 Lakh (FY 2025)Active

Board colleagues of Sushant Kumar

NameDINCompanyDesignation
Akanksha Sinha07759667Trystar Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Trystar Pharma Private Limited
Premium access

Shareholding and investment profile for Sushant Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushant Kumar

Sushant Kumar currently holds 1 directorship: Trystar Pharma Private Limited (Director, since 24 Mar 2017, revenue ₹7.1 Lakh (FY 2025)).

Sushant Kumar was first appointed on 24 Mar 2017 as Director at Trystar Pharma Private Limited.

The current boards of Sushant Kumar's companies include Akanksha Sinha (Trystar Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available